$1.15
-0.02-1.71%
마지막 업데이트: Oct 23, 10:08 AM
Benzinga
Benzinga
Benzinga
금요일, 10월 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Cellectar Biosciences (CLRB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.53 | $-1.78 | $-1.21 | $-2.28 |
| Actual | $-0.57 | $-1.33 | $-0.53 | $-1.41 |
| Surprise | -7.55% | +25.3% | +56.2% | +38.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.54 | $-0.53 | $-0.50 | $-0.68 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.57 | $-0.53 | -7.55 % |
| Q1 | May 14, 2026 | $-1.33 | $-1.78 | 25.3 % |
| Q4 | Mar 4, 2026 | $-0.53 | $-1.21 | 56.2 % |
| Q3 | Nov 13, 2025 | $-1.41 | $-2.28 | 38.2 % |